Elevated plasma total homocysteine levels in hyperinsulinemic obese subjects. (Q51544927)

6 April 2018

title

Elevated plasma total homocysteine levels in hyperinsulinemic obese subjects. (English)

1 reference

6 April 2018

main subject

obesity

0 references

author

Victor Sánchez-Margalet

1

1 reference

6 April 2018

Raimundo Goberna

6

1 reference

6 April 2018

author name string

Miguel Valle

2

1 reference

6 April 2018

Francisco J. Ruz

3

1 reference

6 April 2018

Felix Gascon

4

1 reference

6 April 2018

Joaquijn Mateo

5

1 reference

6 April 2018

publication date

1 February 2002

1 reference

6 April 2018

Journal of Nutritional Biochemistry

published in

1 reference

6 April 2018

volume

13

1 reference

6 April 2018

issue

2

1 reference

6 April 2018

page(s)

75-79

1 reference

6 April 2018

Homocysteine and vascular disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2801%2900197-8

7 January 2021

Genetic and nongenetic factors for moderate hyperhomocyst(e)inemia

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2801%2900197-8

7 January 2021

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2801%2900197-8

7 January 2021

Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2801%2900197-8

7 January 2021

The oxidant stress of hyperhomocyst(e)inemia

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2801%2900197-8

7 January 2021

Homocysteine mediated endothelial cell toxicity and its amelioration

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2801%2900197-8

7 January 2021

Is oxidative stress the missing link between insulin resistance and atherosclerosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2801%2900197-8

7 January 2021

Are insulin resistance and atherosclerosis the consequences of oxidative stress?

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2801%2900197-8

7 January 2021

Oxidative stress disrupts insulin-induced cellular redistribution of insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. A putative cellular mechanism for impaired protein kinase B activation and GLUT4 translocation

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2801%2900197-8

7 January 2021

Evidence for a relationship between free radicals and insulin action in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2801%2900197-8

7 January 2021

Evidence for a relationship between oxidative stress and insulin action in non-insulin-dependent (type II) diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2801%2900197-8

7 January 2021

Relationships between plasma measures of oxidative stress and metabolic control in NIDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2801%2900197-8

7 January 2021

Influence of reduced glutathione infusion on glucose metabolism in patients with non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2801%2900197-8

7 January 2021

Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2801%2900197-8

7 January 2021

Hyperhomocysteinemia following a methionine load in patients with non-insulin-dependent diabetes mellitus and macrovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2801%2900197-8

7 January 2021

Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2801%2900197-8

7 January 2021

Plasma homocysteine concentrations are regulated by acute hyperinsulinemia in nondiabetic but not type 2 diabetic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2801%2900197-8

7 January 2021

Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2801%2900197-8

7 January 2021

Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2801%2900197-8

7 January 2021

Normal pancreastatin-like and increased post-glucose insulin levels in young offspring of insulin-resistant non-obese essential hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2801%2900197-8

7 January 2021

Relationship between obesity and the increased risk of major complications in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2801%2900197-8

7 January 2021

Role of insulin resistance in human disease (syndrome X): an expanded definition

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2801%2900197-8

7 January 2021

Evaluation of oxidative stress in patients with hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2801%2900197-8

7 January 2021

Homocysteine thiolactone inhibits insulin signaling, and glutathione has a protective effect

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2801%2900197-8

7 January 2021

Plasma homocysteine concentrations in healthy volunteers are not related to differences in insulin-mediated glucose disposal.

1 reference

https://api.crossref.org/works/10.1016%2FS0955-2863%2801%2900197-8

7 January 2021

10.1016/S0955-2863(01)00197-8

Identifiers

DOI

1 reference

6 April 2018

1 reference

6 April 2018